sound pharmaceuticals

Sound Pharmaceuticals Advances Phase 2 Clinical Trial in Cystic Fibrosis Patients to Prevent Hearing Loss

SEATTLE, WASHINGTON AND CHARLESTON, SOUTH CAROLINA — Sound Pharmaceuticals, a Seattle-based biotech firm, announced that first-patient-in has been achieved in the STOP Ototoxicity Phase 2 clinical trial. This novel interventional study with the company’s oral drug, SPI-1005, is aimed to prevent and treat ototoxicity in patients with Cystic Fibrosis undergoing intravenous (IV) tobramycin for the…

Read More
decibel partnership cocoon

Decibel Therapeutics and Cocoon Biotech Announce Research Collaboration

BOSTON, MASSACHUSETTS — Biotech startup, Decibel Therapeutics, has announced a research collaboration with Cocoon Biotech to apply Cocoon’s proprietary silk fibroin platform to the development of therapeutics for hearing and balance disorders. According to the announcement, the companies will jointly conduct research into drug formulations optimized for transtympanic delivery to the ear, and Decibel will…

Read More
gn resound artificial intelligence

GN Hearing Launches Artificial Intelligence Feature in Tandem with Apple’s Siri Assistant

BALLERUP, DENMARK — GN Hearing has announced the launch of its new artificial intelligence (AI) solution in tandem with Apple’s Siri virtual assistant. The announcement was made at this year’s Consumer Electronics Show (CES) 2019 in Las Vegas, the world’s largest and most influential technology event.   According to the announcement, the new offering is…

Read More

Nuheara Launches New IQbuds MAX at CES 2019

LAS VEGAS, NEVADA — Australian audio device maker, Nuheara, announced the launch of IQbuds™ MAX at this year’s Consumer Electronics Show (CES) in Las Vegas. The company says the new devices are “the first intelligent hearing buds with Active Noise Cancellation”. IQbuds MAX are the latest addition to Nuheara’s growing lineup of intelligent hearing buds…

Read More

Sensorion Announces Publication of Promising SENS-401 Data

MONTPELLIER, FRANCE — French biotech firm Sensorion announced the publication online, ahead of print, of data in the Otology & Neurology journal, showing the otoprotective potential of twice-daily oral SENS-401 in preclinical models. The company evaluated the efficacy of SENS-401 against severe acoustic trauma-induced hearing loss in a male rat model using auditory brainstem response (ABR), distortion product otoacoustic…

Read More
starkey president prison sentence

Former Starkey President Sentenced to 7 Years in Prison; Former CFO gets 24 Months

MINNEAPOLIS, MINNESOTA — Former Starkey President, Jerry Ruzicka, was sentenced to 7 years in prison on December 19, 2018, for the embezzlement of nearly $20 million from Starkey Hearing Technologies. The sentence was much less than the 15 to 20 years prosecutors had asked for, and also includes a year of probation, fines and restitution.…

Read More
aaa audiology choice act

In Shift, AAA to Offer Support of Audiology Patient Choice Act

RESTON, VIRGINIA — The Board of Directors of the American Academy of Audiology (AAA) announced yesterday that it has voted to endorse the Audiology Patient Choice Act (APCA) on the condition that it include language to provide audiologists with the ability to opt-out of Medicare. According to the announcement, the AAA board feels that the…

Read More
sivantos strong performance

Sivantos Reports Over $1 Billion in Revenue for Fiscal Year 2017/2018

Hearing aid manufacturer Sivantos has released results of its fiscal year 2017/2018, posting strong performance for the year (October 1, 2017 through September 30, 2018). According to the company news release, sales grew by 14% to reach 1.1 Billion Euros (approximately $1.25 Billion USD).  The company says that it out-performed the market in key countries,…

Read More
ida institute research grants

Ida Institute Now Accepting Proposals for 2019 Research Grant

NAERUM, DENMARK — The Ida Institute Research Committee announced that it is now accepting proposals for the 2019 Ida Research Grant. Funding will be awarded to projects that develop evidence related to Ida Institute methods and tools and aim to demonstrate the effect of person-centered practice in hearing care.  In 2019, the Research Committee is particularly interested in projects…

Read More